It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 | Hyderabad, Telangana, India | ActiveChantilly Bio Pharma Private Limited, a active private limited company, was established on 04 July 2011 in Hyderabad, Telangana, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U74999TG2011PTC075331. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.17 M.
It upholds a compliant status. Its leadership includes Nagajyothi Balusu (Director), Kanaka Malneedi Durga (Director), Cherukuri Subraman Rao (Managing Director). Past directors included Venkata Nageswara Rao Cherukuri, Kanaka Malneedi Durga. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No.11-150/15 & 16, 2 Nd Floor,Sri Sai Sadan, Patwari Enclave,Gandhinagar, Balanagar,, Hyderabad, Telangana, 500037.
U74999TG2011PTC075331
075331
04 July 2011
₹1.20 M
₹1.17 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Chantilly Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagajyothi Balusu | Director | 08 Jun 2019 | Current |
| Kanaka Malneedi Durga | Director | 04 Jul 2011 | Current |
| Cherukuri Subraman Rao | Managing Director | 06 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jan 2016 | Past |
| Pramod Abcsdd | Managing Director | 06 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chantilly Bio Pharma Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 23.69% decrease. The company also saw a substantial fall in profitability, with a 120.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Chantilly Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Chantilly Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chantilly Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chantilly Bio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chantilly Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Chantilly Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on Nagajyothi Balusu was appointed as a Director was appointed as a Director on 08 Jun 2019 & has been associated with this company since 6 years 6 months . was documented.
Progress on Cherukuri Subraman Rao was appointed as a Managing Director was appointed as a Managing Director on 06 Apr 2015 & has been associated with this company since 10 years 8 months . was documented.
Kanaka Malneedi Durga was appointed as a Director was appointed as a Director on 04 Jul 2011 & has been associated with this company since 14 years 5 months . was recorded as a recent event.
Progress on Chantilly Bio Pharma Private Limited was registered on 04 Jul 2011 with Roc Hyderabad & aged 14 years 5 months as per MCA records. was documented.
The CIN of Chantilly Bio Pharma Private Limited is U74999TG2011PTC075331.
Chantilly Bio Pharma Private Limited is headquartered at H.No.11-150/15 & 16, 2 Nd Floor,Sri Sai Sadan, Patwari Enclave,Gandhinagar, Balanagar,, Hyderabad, Telangana, 500037.
Chantilly Bio Pharma Private Limited was incorporated on 04 July 2011.
The current directors of Chantilly Bio Pharma Private Limited are
The primary industry of Chantilly Bio Pharma Private Limited is Professional, Scientific And Technical.
Chantilly Bio Pharma Private Limited is unlisted.
The authorized capital of Chantilly Bio Pharma Private Limited is ₹1.20 M, and the paid-up capital is ₹1.17 M.
The compliance status of Chantilly Bio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX